Merck KGaA (OTCMKTS:MKKGY) Receives Average Rating of “Hold” from Analysts

Merck KGaA (OTCMKTS:MKKGY) has earned an average recommendation of “Hold” from the six research firms that are covering the firm, Marketbeat Ratings reports. Six analysts have rated the stock with a hold recommendation.

A number of brokerages recently commented on MKKGY. UBS Group cut Merck KGaA from a “strong-buy” rating to a “hold” rating in a research note on Thursday, August 20th. HSBC raised Merck KGaA to a “hold” rating in a research note on Monday, July 6th. Finally, Zacks Research lowered Merck KGaA from a “strong-buy” rating to a “hold” rating in a research report on Thursday, August 20th.

Merck KGaA Trading Up 0.7%

OTCMKTS:MKKGY opened at $30.86 on Tuesday. The business’s 50-day simple moving average is $31.81 and its 200 day simple moving average is $29.68. The stock has a market cap of $19.94 billion, a price-to-earnings ratio of 15.91, a price-to-earnings-growth ratio of 2.92 and a beta of 0.96. Merck KGaA has a one year low of $23.73 and a one year high of $34.19. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.09 and a current ratio of 1.69.

About Merck KGaA

Merck KGaA is a Germany-based science and technology company headquartered in Darmstadt. Founded in 1668, it is one of the world’s oldest pharmaceutical and chemical businesses. Merck KGaA operates independently from the U.S.-based Merck & Co, Inc, which uses the name MSD in markets outside the United States and Canada.

The company operates through three primary business sectors: Life Science, Healthcare and Electronics. Its Life Science business supplies laboratory products, research tools, bioprocessing equipment and services used by academic institutions, pharmaceutical manufacturers and other industrial customers.